Alex Sapir
CEO and President
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q1 2026 earnings conference call, held 2026-04-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alan Musso
Chief Financial Officer
Dr. Ian Frazier
Senior Vice President, Clinical Development
Joe Schwartz
Analyst, Leerink Partners
Anupam Rama
Analyst, JP Morgan
Kristin Kosko
Analyst, Cantor
Corinne Johnson
Analyst, Goldman Sachs
James Condalus
Analyst, Stifel
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.534 Good morning and welcome to Fulcrum Therapeutics First Quarter 2026 Financial Results 00:00:04.534 -- 00:00:09.819 and Business Update Conference Call. Currently, all participants are in listen-only mode. 00:00:09.819 -- 00:00:13.742 This call is being webcast live and can be accessed on the Investors section of Fulcrum's 00:00:13.742 -- 00:00:16.642 website at www.FulcrumTX.com 00:00:17.685 -- 00:00:19.926 and is being recorded. 00:00:19.926 -- 00:00:23.429 Please be reminded that remarks during this call may contain forward-looking statements 00:00:23.429 -- 00:00:28.120 within the meaning of the private security's litigation reform Act 1995. 00:00:28.120 -- 00:00:32.684 may include statements about the company's future expectations and plans, clinical development 00:00:32.684 -- 00:00:35.446 timelines, and financial projections. 00:00:35.446 -- 00:00:39.549 While these forward-looking statements represent Fulcrum's views as of today, they should 00:00:39.549 -- 00:00:43.192 not be relied upon as representing the company's views in the future. 00:00:43.192 -- 00:00:47.516 Fulcrum may update these statements in the future, but is not taking on an obligation 00:00:47.516 -- 00:00:52.059 to do so. Please refer to Fulcrum's most recent files with the Securities and Exchange 00:00:52.059 -- 00:00:56.123 Commission for discussions of certain risks and uncertainties associated with the company's 00:00:56.123 -- 00:00:58.123 business. 00:00:58.492 -- 00:01:02.956 Leading the call today will be Alex Sapir, CEO and President of Fulcrum. 00:01:02.956 -- 00:01:06.198 Joining Alex on the call are Alan Musso, Chief Financial Officer, and Dr. 00:01:06.198 -- 00:01:09.701 Ian Frazier, Senior Vice President, Clinical Development. 00:01:09.701 -- ...